Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Complement Therapeutics Limited has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This workload involves 1 distinct examiner, indicating that the company's current prosecution efforts are focused on a single point of contact. The activity is confined to 1 distinct art unit, which implies a concentrated technical focus for the pending claims under review. This alignment suggests that the company is pursuing a specific technical advancement within a well-defined niche of the biotechnology field.
HELLMAN, KRISTINA M is the busiest examiner for the company, handling 1 pending office action. Since the busiest examiner pending count of 1 is equal to the total number of pending actions, this examiner has sole oversight of the company's active applications. Success in this technology area currently depends on addressing the specific requirements of this 1 examiner within the designated art unit. This streamlined prosecution environment allows for a very specific response strategy that accounts for the examiner's unique technical perspective.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HELLMAN, KRISTINA M | 1 | 65.3% | +55.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18184427 | COMPLEMENTOME ASSAY | HELLMAN, KRISTINA M | 63d |
| Art Unit | Apps |
|---|---|
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18184427 | COMPLEMENTOME ASSAY | HELLMAN, KRISTINA M | 1654 | §102§103§112DPOther | Non-Final OA | 63d | Pending | Mar 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial